VIICTR
Profiles
ORIT
Pediatrics CRA
Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Neoadjuvant Talazoparib for Patients With Operable Breast Cancer With a Germline BRCA Pathogenic Variant.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Neoadjuvant Talazoparib for Patients With Operable Breast Cancer With a Germline BRCA Pathogenic Variant.
Neoadjuvant Talazoparib for Patients With Operable Breast Cancer With a Germline BRCA Pathogenic Variant. J Clin Oncol. 2020 02 10; 38(5):388-394.
View in:
PubMed
subject areas
Administration, Oral
Adult
BRCA1 Protein
BRCA2 Protein
Breast Neoplasms
Chemotherapy, Adjuvant
Female
Germ-Line Mutation
Humans
Medication Adherence
Middle Aged
Neoadjuvant Therapy
Phthalazines
Pilot Projects
Poly(ADP-ribose) Polymerase Inhibitors
Triple Negative Breast Neoplasms
authors with profiles
NUHAD K IBRAHIM
KENNETH R HESS
VICENTE VALERO
GARY J WHITMAN
CARLOS HERNANDO BARCENAS
BANU K ARUN
ABENAA BREWSTER
JENNIFER LITTON
ELIZABETH ANN MITTENDORF
STACY MOULDER
BEATRIZ ELENA ADRADA
SARAH MARIE DESNYDER
RASHMI KRISHNA MURTHY
MARION ELIZABETH SCOGGINS
HELEN PIWNICA-WORMS
SENTHIL DAMODARAN